Foundation Medicine Secures $42,500,000 Series B Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8762ba46-9d11-4175-ab0e-f87effe6343c&Preview=1 - Date
9/21/2012 - Company Name
Foundation Medicine - Mailing Address
One Kendall Square Boston, MA 02139 - Company Description
The trick to beating cancer could be a single test that shows all known genetic traits in each person’s tumor, and that also matches those results to the best treatments. - Website
http://www.foundationmedicine.com - Transaction Type
Venture Equity - Transaction Amount
$42,500,000 - Transaction Round
Series B - Proceeds Purposes
The proceeds from the financing will help Foundation Medicine expand commercial operations, scale laboratory capabilities and develop additional genomic profiling and information services. - M&A Terms
- Venture Investor
Deerfield Capital - Venture Investor
Casdin Capital - Venture Investor
Redmile Group - Venture Investor
Roche Venture Fund - Venture Investor
WuXi PharmaTech - Venture Investor
Third Rock Ventures - Venture Investor
Google Ventures - Venture Investor
Kleiner Perkins Caufield & Byers
